Predicting Hospital Readmissions in Patients Receiving Novel-Dose Sacubitril/Valsartan Therapy: A Competing-Risk, Causal Mediation Analysis

• Published in: Journal of cardiovascular pharmacology and therapeutics Vol. 28; p. 10742484231219603
• Main Authors: Hou, Changchun, Hao, Xinxin, Sun, Ning, Luo, Xiaolin, Gao, Zhichun, Chen, Ling, Liu, Xi, Qin, Zhexue
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 01.01.2023; SAGE Publishing
• Subjects: prediction; hospital readmission; heart failure; Sacubitril/Valsartan

Backgrounds: Our study aimed to identify and predict patients with heart failure (HF) taking novel-dose Sacubitril/Valsartan (S/V) at risk for all-cause readmission, as well as investigate the possible role of left ventricular reverse remodeling (LVRR). Methods and results: There were 464 patients r...